000 | 01529 a2200397 4500 | ||
---|---|---|---|
005 | 20250512001722.0 | ||
264 | 0 | _c19870826 | |
008 | 198708s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSolovera, J J | |
245 | 0 | 0 |
_aInhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cAug 1987 |
||
300 |
_a876-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology |
650 | 0 | 4 |
_aCalcium _xphysiology |
650 | 0 | 4 |
_aCalmodulin _xantagonists & inhibitors |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
650 | 0 | 4 | _aDepression, Chemical |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aExocytosis _xdrug effects |
650 | 0 | 4 |
_aHaloperidol _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aIon Channels _xdrug effects |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aNifedipine _xpharmacology |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
700 | 1 | _aAlvarez-Mon, M | |
700 | 1 | _aCasas, J | |
700 | 1 | _aCarballido, J | |
700 | 1 | _aDurantez, A | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 139 _gno. 3 _gp. 876-80 |
|
999 |
_c2445653 _d2445653 |